Bellows Charles F, Alder Adam, Helton W Scott
Michael E DeBakey VAMC, M/C 112, 2002 Holcombe Blvd, Houston, TX 77030, USA.
Expert Rev Med Devices. 2006 Sep;3(5):657-75. doi: 10.1586/17434440.3.5.657.
Surgeons often encounter the challenge of treating acquired abdominal wall defects following abdominal surgery. The current standard of practice is to repair most defects using permanent synthetic mesh material. Mesh augments the strength of the weakened abdominal wall fascia and enables the hernia repair to be performed in a tension-free manner. However, there is a risk of acute and/or chronic infection, fistula formation and chronic abdominal wall pain with the use of permanent mesh materials, which can lead to more complex operations. As a means to avoid such problems, surgeons are turning increasingly to the use of xenogenic and allogenic materials for the repair of abdominal wall defects. Their rapid evolution and introduction into the clinical operating room is leading to a new era in abdominal wall reconstruction. There are promising, albeit limited, clinical data with short-term follow-up for only a few of the many biological tissue grafts that are being promoted currently for the repair of abdominal hernias. Additional clinical studies are required to better understand the long-term efficacy and limitations of these materials.
外科医生在治疗腹部手术后获得性腹壁缺损时经常面临挑战。目前的标准做法是使用永久性合成网片材料修复大多数缺损。网片可增强薄弱的腹壁筋膜的强度,并使疝修补能够在无张力的情况下进行。然而,使用永久性网片材料存在急性和/或慢性感染、瘘管形成以及慢性腹壁疼痛的风险,这可能导致更复杂的手术。作为避免此类问题的一种方法,外科医生越来越多地转向使用异种和同种异体材料来修复腹壁缺损。它们的迅速发展并引入临床手术室正在引领腹壁重建的新时代。对于目前正在推广用于修复腹疝的众多生物组织移植物中的少数几种,仅有短期随访的、虽有前景但有限的临床数据。还需要更多的临床研究来更好地了解这些材料的长期疗效和局限性。